Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF, AND PHARMACEUTICAL USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/012434
Kind Code:
A1
Abstract:
Provided are receptor tyrosine kinase like orphan receptor 1 antibodies or antigen-binding fragments, and their pharmaceutical use.

More Like This:
WO/2015/130975METHODS FOR TREATING SKIN INFECTION BY ADMINISTERING AN IL-4R ANTAGONIST
JP2005139205THERAPEUTIC AGENT FOR INFANT CHRONIC ARTHRITIS-RELATING DISEASE
WO/2019/195621METHODS AND COMPOSITIONS FOR BLOCKING INTERACTION BETWEEN NON-GLYCOSYLATED PD-1 POLYPEPTIDES
Inventors:
LI QING (US)
LIU XINQUAN (US)
LO LARRY (US)
Application Number:
PCT/CN2023/106728
Publication Date:
January 18, 2024
Filing Date:
July 11, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HANSOH BIO LLC (US)
SHANGHAI HANSOH BIOMEDICAL CO LTD (CN)
CHANGZHOU HANSOH PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61K47/68; A61P35/00; C07K16/40
Foreign References:
CN112154157A2020-12-29
CN103429618A2013-12-04
CN110590951A2019-12-20
CN114539411A2022-05-27
US20120058051A12012-03-08
CN110891973A2020-03-17
CN107847596A2018-03-27
CN113980133A2022-01-28
Attorney, Agent or Firm:
GE CHENG & CO., LTD. (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: REFRIGERATOR FLIPPING SYSTEM

Next Patent: GENE EDITING SYSTEMS AND METHODS FOR TREATING HEREDITARY ANGIOEDEMA